Age and the relation of common neuropathologies to dementia in Brazilian adults
Farfel, J. M.; Nag, S.; Capuano, A. W.; Sampaio, M. C.; Poole, V. N.; Wilson, R. S.; Bennett, D. A.
Show abstract
BackgroundCommunity-based clinical-pathologic studies have been instrumental to examine the association of Alzheimers disease and related disorders (AD/ADRD) with age and dementia in very-old non-Latino Whites. Here, we show the age distribution of four AD and three additional common neuropathologies across the adult lifespan and examine their relation to dementia and cognitive impairment in old and young Brazilian adults. MethodsWe examined 5,376 brains from decedents age 18 years or older (52.5% male, 39.8% Black), from the Pathology, Alzheimers and Related Dementias Study (PARDoS), collected between July 2021 and September 2025. Clinical diagnoses were rendered by a clinician who reviewed the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), informant-based Clinical Dementia Rating (CDR) Scale, and other selected data. Four indices of AD including {beta}-amyloid deposits (Thal stage), PHF-tau tangles (Braak stage), neocortical phosphorylated plaques and AD neuropathologic change (ADNC), and three other common neuropathologies, i.e., Lewy-body disease (LBD), chronic gross infarcts, and cerebral amyloid angiopathy (CAA) were assessed. Logistic regression was used for associations of pathologies with clinical diagnoses, adjusting for demographics. ResultsIntermediate to high ADNC were first found as early as the fourth decade. Chronic gross infarcts were found in one-fifth of the brains of young adults. Intermediate to high ADNC, limbic and neocortical LBD, chronic gross infarct and moderate to severe CAA were associated with dementia and cognitive impairment (CI) in older adults with mixed pathologies being the most common. Intermediate to high ADNC was associated with CI but not dementia in young adults, whereas, chronic gross infarcts were associated with both CI and dementia in young adults; overall, mixed pathologies were a small minority. ConclusionIn a community-based, clinical-pathologic study including 5300+ brains from diverse Brazilians, we show that AD and other common pathologies frequently begin in young adulthood. In older adults, mixed pathologies are most commonly associated with dementia, whereas in young adults a single pathology, most commonly chronic gross infarcts rather than ADNC is related to dementia.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Alzheimer Disease Neuropathological Comorbidities Are Common in the Younger-Old 98%
- Risk models based on non-cognitive measures may identify presymptomatic Alzheimer’s disease 97%
- The Association of Alzheimer’s Disease-related Blood-based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa 96%
Similar papers in this journal
- Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease 96%
- White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer’s disease continuum 96%
- Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort 95%
Similar papers in this journal
- Delayed primacy recall performance predicts post mortem Alzheimers disease pathology from unimpaired ante mortem cognitive baseline 97%
- The Temporal Relationships between White Matter Hyperintensities, Neurodegeneration, Amyloid β, and Cognition 96%
- Association of Item-Level Responses to Cognitive Function Index with Tau Pathology and Hippocampal volume in The A4 Study 95%
Similar papers in this journal
- Association between motor task acquisition and hippocampal atrophy across cognitively unimpaired, amnestic Mild Cognitive Impairment, and Alzheimer’s disease individuals 95%
- Sex Differences in Cognitive Performance in Alzheimer's Disease: Insights from the ADAS-Cog-13 95%
- Profiles of cognitive change in preclinical Alzheimer's disease using change-point analysis 95%